Diosgenin Attenuates Angiogenesis via Targeting Src/STAT3 Signaling Pathway to Treat Non-Small Cell Lung CancerOA
Diosgenin Attenuates Angiogenesis via Targeting Src/STAT3 Signaling Pathway to Treat Non-Small Cell Lung Cancer
LI Wan-yu;WANG Yu-han;WANG Qing-ting;YANG Xi-wen;ZHANG Shi;ZHANG Zhou-ji;ZHANG Ming
Department of Integrated Traditional Chinese and Western Medicine,Shanghai Chest Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai(200030),ChinaDepartment of Integrated Traditional Chinese and Western Medicine,Shanghai Chest Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai(200030),ChinaDepartment of Integrated Traditional Chinese and Western Medicine,Shanghai Chest Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai(200030),ChinaShanghai Literature Institute of Traditional Chinese Medicine,Shanghai(200030),ChinaDepartment of Integrated Traditional Chinese and Western Medicine,Shanghai Chest Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai(200030),ChinaDepartment of Integrated Traditional Chinese and Western Medicine,Shanghai Chest Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai(200030),ChinaDepartment of Integrated Traditional Chinese and Western Medicine,Shanghai Chest Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai(200030),China
lung cancerdiosgeninChinese medicineanti-angiogenesisnetwork pharmacology
lung cancerdiosgeninChinese medicineanti-angiogenesisnetwork pharmacology
《中国结合医学杂志（英文版）》 2026 (7)
603-612,10
Supported by National Natural Science Foundation of China(No.81873275),Science and Technology Innovation Action Plan of Shanghai Municipal Commission of Science and Technology(No.20Y21900600),Youth Guidance Project of Shanghai Municipal Administration of Traditional Chinese Medicine,Shanghai Municipal Health Commission(No.2022QN033)
评论